Magnetic resonance technology is continually improving. Functional imaging techniques such as magnetic resonance spectroscopy, perfusion imaging, diffusion imaging, and diffusion tensor imaging are increasingly used in the diagnosis and treatment of brain tumors in children. However, estimate of tumor size remains the primary imaging endpoint in the evaluation of response to treatment, and validation across institutions and vendor platforms of magnetic resonance imaging functional parameters is necessary given the relatively uncommon occurrence of brain tumors in children. Pediatric neuroimaging can be challenging, and the optimal way to image children with tumors of the central nervous system is not uniformly applied across all centers. Application of proper scanning techniques and validation of functional imaging techniques should lead to improved care of children with central nervous system tumors.
Dandy WEVentriculography following the injection of air into the cerebral ventricles . Ann Surg. 1918;68:5-11.
2.
Koeller KK, Henry JMSuperficial gliomas: radiologic-pathologic correlation. Radiographics . 2001;21:1533-1556.
3.
Zimmerman RA , Haselgrove JC, Bilaniuk LT, Hunter JVDiffu- 2 sion-weighted imaging and fluid attenuated inversion recovery imaging in the evaluation of primitive neuroectodermal tumors. Neuroradiology. 2001;43:927-933.
4.
Fischbein NJ , Prados MD, Wara W., et al. Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg. 1996;24:9-23.
5.
Shaw DW, Geyer JR, Berger MS, et al. Asymptomatic recurrence 2 detection with surveillance scanning in children with medulloblastoma. J Clin Oncol. 1997;15:1811-1813.
6.
Saunders DE, Hayward RD, Phipps KP, et al. Surveillance neuroimaging of intracranial medulloblastoma in children: how effective, how often, and for how long?J Neurosurg . 2003;99: 280-286.
7.
Bogomolny DL , Petrovich NM, Hou BL, et al. Functional MRI in the brain tumor patient. Top Magn Reson Imaging. 2004;15: 325-335.
8.
Narayana A., Chang J., Thakur S., et al. Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. Br J Radiol. 2007;80:347-354.
9.
McKnight TR, Lamborn KR, Love TD, et al. Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. J Neurosurg. 2007;106: 660-666.
10.
Stadlbauer A., Gruber S., Nimsky C., et al. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology. 2006;238:958-969.
11.
Tzika A., Zurakowski D., Poussaint TY, et al. Proton magnetic spectroscopic imaging of the child's brain: the response of tumors to treatment. Neuroradiology. 2001;43:169-177.
12.
Warren KE, Frank JA, Black JL, et al. Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors. J Clin Oncol. 2000;18:1020-1026.
13.
Tzika AA, Astrakas LG, Zarifi MK, et al. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors. Cancer. 2004;100:1246-1256.
14.
Panigrahy A. , Krieger MD, Gonzalez-Gomez I., et al. Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: preoperative diagnosis and characterization. AJNR Am J Neuroradiol. 2006;27:560-572.
15.
Pirzkall A. , McKnight TR, Graves EE, et al. MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys. 2001;50:915-928.
16.
Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology. 1994;191:41-51.
17.
Schmainda KM , Rand SD, Joseph AM, et al. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. AJNR Am J Neuroradiol. 2004;25:1524-1532.
18.
Law M., Oh S., Babb JS, et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging-prediction of patient clinical response. Radiology. 2006;238:658-667.
19.
Pollack IF, Jakacki RI, Blaney SM, et al. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report . Neuro Oncol. 2007;9:145-160.
20.
Cha S., Knopp EA, Johnson G. et al: Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology. 2002;223:11-29.
21.
Roberts HC, Roberts TP, Brasch RC, Dillon WPQuantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol. 2000;21:891-899.
22.
Haroon HA, Patankar TF, Zhu XP, et al. Comparison of cerebral blood volume maps generated from T2* and T1 weighted MRI data in intra-axial cerebral tumours. Br J Radiol. 2007;80:161-168.
23.
Higano S., Yun X., Kumabe T., et al. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology. 2006;241:839-846.
24.
Miller JH, McKinstry RC, Philip JV, et al. Diffusion-tensor MR imaging of normal brain maturation: a guide to structural development and myelination. AJR Am J Roentgenol . 2003;180:851-859.
25.
Jellison BJ, Field AS, Medow J., et al. Diffusion tensor imaging of cerebral white matter: a pictorial review of physics, fiber tract anatomy, and tumor imaging patterns. AJNR Am J Neuroradiol. 2004;25:356-369.
26.
Talos IF, Zou KH, Kikinis R., Jolesz FAVolumetric assessment of tumor infiltration of adjacent white matter based on anatomic MRI and diffusion tensor tractography. Acad Radiol . 2007;14:431-436.
27.
Helton KJ, Phillips NS, Khan RB, et al. Diffusion tensor imaging of tract involvement in children with pontine tumors. AJNR Am J Neuroradiol. 2006 ;27:786-793.
28.
Khong PL, Leung LH, Chan GC, et al. White matter anisotropy in childhood medulloblastoma survivors: association with neurotoxicity risk factors. Radiology. 2005;236:647-652.
29.
Schmahmann JD, Pandya DN, Wang R., et al. Association fibre pathways of the brain: parallel observations from diffusion spectrum imaging and autoradiography . Brain. 2007;130:630-653.
30.
Packer RJ, Gajjar A., Vezina G., et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24:4202-4208.
